DocSym
β
Searchsearch
Search
(D09.0) Carcinoma in situ: bladder
More details coming soon
122 821 in individuals diagnosis carcinoma in situ: bladder confirmed
1 183 deaths with diagnosis carcinoma in situ: bladder
1% mortality rate associated with the disease carcinoma in situ: bladder
Diagnosis carcinoma in situ: bladder is diagnosed Men are 26.73% more likely than Women
77 824
Men receive the diagnosis carcinoma in situ: bladder
1 183 (1.5 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
44 997
Women receive the diagnosis carcinoma in situ: bladder
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease carcinoma in situ: bladder - Men aged 60-64 and Women aged 65-69
In Men diagnosis is most often set at age 15-19, 25-94
Less common in men the disease occurs at Age 0-14, 20-24, 95+Less common in women the disease occurs at Age 0-19, 95+
In Women diagnosis is most often set at age 20-94
Disease Features carcinoma in situ: bladder
Absence or low individual and public risk
Carcinoma in situ: bladder - what does this mean
Carcinoma in situ of the bladder is a type of non-invasive cancer where abnormal cells are found in the bladder lining. these cells have not spread beyond the bladder lining and have not invaded deeper into the bladder wall.
What happens during the disease - carcinoma in situ: bladder
Carcinoma in situ of the bladder is caused by damage to the dna of bladder cells, leading to uncontrolled cell growth and the accumulation of abnormal cells. this can be caused by environmental factors such as exposure to certain chemicals, radiation, or a weakened immune system, or by genetic factors such as inherited mutations in certain genes. the abnormal cells can spread to other parts of the bladder and may progress to invasive cancer if not treated.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Urinalysis
- Cystoscopy
- Biopsy
- Imaging Studies (CT Scan, MRI)
- Urine Cytology
- Urine Culture
- Blood Tests
Treatment and Medical Assistance
Main goal: Treat the Carcinoma in situ: Bladder
- Consult with a Urologist
- Undergo tests such as cystoscopy and urine cytology
- Receive a biopsy
- Undergo surgery to remove the cancerous cells
- Receive chemotherapy
- Receive radiation therapy
- Receive immunotherapy
- Undergo follow-up tests to monitor for any recurrence
10 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Carcinoma in situ: bladder - Prevention
Carcinoma in situ of the bladder can be prevented by avoiding smoking, drinking plenty of water, maintaining a healthy diet, and avoiding exposure to certain chemicals and toxins. regular screenings are also recommended for those at higher risk.